Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiyi Feng

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Genome Medicine|November 20, 2021
Genome-wide identification and characterization of circular RNA m<sup>6</sup>A modification in pancreatic cancerYing Ye, Weiyi Feng, Jialiang Zhang, et al.
International Journal of Cancer|August 23, 2018
Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinomaFeng Ye, Hongwei Gao, Lin Xiao, et al.
Frontiers in Pharmacology|December 9, 2024
Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition)Boxin Zhao, Xuan Zhou, Ping Zheng, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Genome Medicine|November 20, 2021
Genome-wide identification and characterization of circular RNA m<sup>6</sup>A modification in pancreatic cancerYing Ye, Weiyi Feng, Jialiang Zhang, et al.
International Journal of Cancer|August 23, 2018
Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinomaFeng Ye, Hongwei Gao, Lin Xiao, et al.
Frontiers in Pharmacology|December 9, 2024
Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition)Boxin Zhao, Xuan Zhou, Ping Zheng, et al.
Pageof 7